Bruker (BRKR) Q3 FY2026 earnings: revenue $874 million, up 1.6% on the year

Bruker Corp. (BRKR) reported revenue of $874 million for Q3 FY2026, the quarter ended 30 September 2026, up 1.6% on the same quarter a year earlier. Net income was -$112 million, and diluted earnings per share $-0.81. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.

Revenue

$874 million

+1.6% on the year · +4.2% on the quarter

Q4 FY2024Q3 FY2026

Operating margin

-10.4%

-6.0% a year earlier

Q4 FY2024Q3 FY2026

Net income

-$112 million

Q4 FY2024Q3 FY2026

Diluted EPS

-$0.81

Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 2 lowered, 1 new, 4 kept.

Revenue rose 1.6% year over year: Revenue was $874.0 million against $860.5 million. Organic revenue growth was 0.7%, and acquisitions added 1.7%.
Non-GAAP operating margin up 400 basis points: Non-GAAP operating income was $142.6 million against $105.9 million, and non-GAAP operating margin was 16.3% against 12.3%.
Non-GAAP EPS rose 24.4%: Non-GAAP diluted EPS was $0.56 against $0.45 a year earlier. GAAP diluted loss per share was $(0.81), against $(0.41).

Read the earnings call summary

Income statement (profit and loss)

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Revenue	874	838	860	+4.2%	+1.6%
Cost of revenue	445	422	481	+5.3%	-7.6%
Gross profit	429	416	379	+3.2%	+13.2%
Gross margin	49.1%	49.6%	44.1%
Research and development	92.0	94.3	98.3	-2.4%	-6.4%
Selling, general and administrative	226	239	242	-5.2%	-6.6%
Operating income	-91.0	-65.3	-51.8
Operating margin	-10.4%	-7.8%	-6.0%
Interest expense	15.4	17.8	20.3	-13.5%	-24.1%
Pre-tax income	-120	-40.7	-71.8
Income tax	-12.2	14.2	-14.1
Net income	-112	-52.0	-59.6
Net margin	-12.8%	-6.2%	-6.9%
Diluted EPS	-$0.81	-$0.41	-$0.41

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Operating cash flow	118	-77.4	-33.2
Capital expenditure	21.5	28.8	20.9	-25.3%	+2.9%
Free cash flow	96.7	-106	-54.1
Free cash flow margin	11.1%	-12.7%	-6.3%
Cash from investing	-72.7	-25.3	-23.8
Cash from financing	-110	149	258
Depreciation and amortisation	54.1	58.0	55.7	-6.7%	-2.9%
Share-based compensation	6.1	5.6	6.0	+8.9%	+1.7%
Buybacks	n/a	n/a	0.0
Dividends paid	7.7	7.5	0.0	+2.7%
Dividend per share	n/a	n/a	$0.05
Diluted shares, weighted	152m	152m	152m	+0.1%	+0.5%
Shares outstanding at period end	153m	152m	151m	+0.2%	+0.9%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Shareholders' equity	2,306	2,400	2,432	-3.9%	-5.2%
Non-controlling interest	n/a	n/a	17.6
Redeemable equity	37.0	35.6	42.9	+3.9%	-13.8%
Debt	1,713	1,825	2,008	-6.1%	-14.7%
Other liabilities	1,772	1,792	1,934	-1.1%	-8.4%
Total liabilities and equity	5,828	6,053	6,435	-3.7%	-9.4%
Fixed assets	696	714	747	-2.6%	-6.8%
Goodwill	1,290	1,430	1,550	-9.8%	-16.8%
Intangible assets	859	868	919	-1.0%	-6.5%
Cash and equivalents	120	185	293	-35.3%	-59.2%
Receivables	564	546	551	+3.3%	+2.4%
Inventory	1,103	1,120	1,197	-1.6%	-7.8%
Other assets	1,198	1,190	1,179	+0.6%	+1.6%
Total assets	5,828	6,053	6,435	-3.7%	-9.4%

Questions

What was Bruker's revenue in Q3 FY2026?

Bruker (BRKR) reported revenue of $874 million for Q3 FY2026, the quarter ended 30 September 2026, up 1.6% on the same quarter a year earlier.

How much did Bruker earn in Q3 FY2026?

Net loss for Q3 FY2026 was $112 million, and the diluted loss per share $0.81.

When did Bruker report Q3 FY2026 results?

Bruker filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.

Quarterly results, the last 20 quarters

	Q4 FY2021 *	Q1 FY2022	Q2 FY2022	Q3 FY2022	Q4 FY2022 *	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026
Revenue	684	595	588	639	708	685	682	743	854	722	801	864	980	801	797	860	977	823	838	874
Cost of revenue	342	289	290	304	342	326	341	360	424	369	416	446	486	410	440	481	528	444	422	445
Gross profit	342	306	298	335	366	360	340	383	430	353	385	419	493	391	358	379	449	380	416	429
Gross margin	50%	51%	51%	52%	52%	52%	50%	52%	50%	49%	48%	48%	50%	49%	45%	44%	46%	46%	50%	49%
R&D	58.1	56.6	59.6	56.2	63.5	69.0	71.0	71.3	83.5	81.8	92.2	98.1	104	97.1	100	98.3	99.6	101	94.3	92.0
SG&A	153	146	152	145	165	163	178	178	211	195	221	230	247	225	231	242	247	242	239	226
Operating income	125	96.5	73.9	131	131	123	86.2	124	104	64.8	48.1	68.1	72.1	31.8	11.9	-51.8	76.3	10.2	-65.3	-91.0
Operating margin	18%	16%	13%	21%	18%	18%	13%	17%	12%	9%	6%	8%	7%	4%	1%	-6%	8%	1%	-8%	-10%
Interest expense	n/a	4.1	-4.0	3.7	12.3	4.2	-3.9	3.9	12.2	5.0	15.7	11.6	15.6	13.1	15.7	20.3	11.2	12.2	17.8	15.4
Pre-tax income	120	94.0	69.6	129	121	107	77.5	119	241	71.6	23.9	55.3	56.1	25.1	0.5	-71.8	68.2	21.9	-40.7	-120
Tax rate	36%	34%	29%	32%	19%	28%	26%	26%	15%	28%	67%	27%	73%	35%	-620%	n/a	55%	11%	n/a	n/a
Net income	75.7	61.6	49.5	88.1	97.4	76.5	57.1	88.1	206	50.9	7.6	40.9	13.7	17.4	7.6	-59.6	26.0	14.4	-52.0	-112
Net margin	11%	10%	8%	14%	14%	11%	8%	12%	24%	7%	1%	5%	1%	2%	1%	-7%	3%	2%	-6%	-13%
Diluted EPS	$0.49	$0.41	$0.33	$0.59	$0.66	$0.52	$0.39	$0.60	$1.41	$0.35	$0.05	$0.27	$0.09	$0.11	$0.05	-$0.41	$0.10	$0.02	-$0.41	-$0.81
Operating cash flow	139	77.8	-44.4	69.5	172	87.5	13.0	44.1	206	21.8	1.1	38.4	190	65.0	-128	-33.2	230	71.2	-77.4	118
Capital expenditure	28.4	19.0	17.9	57.7	34.6	25.0	23.5	26.9	31.5	21.4	24.6	32.6	36.7	26.0	21.3	20.9	22.6	24.2	28.8	21.5
Free cash flow	110	58.8	-62.3	11.8	137	62.5	-10.5	17.2	174	0.4	-23.5	5.8	153	39.0	-149	-54.1	207	47.0	-106	96.7
Buybacks	82.2	106	60.3	70.9	26.3	22.4	0.0	79.5	50.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	n/a	n/a
Dividends paid	6.0	7.5	7.5	7.4	7.4	7.4	7.3	7.4	7.3	7.3	7.7	7.6	7.6	7.7	7.6	0.0	7.5	7.6	7.5	7.7
Shares outstanding	151m	149m	148m	147m	147m	147m	147m	146m	145m	145m	151m	152m	152m	152m	152m	151m	152m	152m	152m	153m
Filing	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.